Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;76(9):2910-2913.
doi: 10.1111/all.14953. Epub 2021 Jun 7.

Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection

Affiliations

Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection

Sinead Ahearn-Ford et al. Allergy. 2021 Sep.
No abstract available

Keywords: COVID; SARS-CoV-2; inflammation; interleukins.

PubMed Disclaimer

Conflict of interest statement

Dr. O'Mahony reports grants from Science Foundation Ireland, during the conduct of the study; grants from GSK; and personal fees from PrecisionBiotics, outside the submitted work. None of the other authors report any conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Proinflammatory and endothelial mediators in post‐COVID patients. Proinflammatory mediators (A) and angiogenesis‐associated factors (B) are elevated in sera from patients 3–9 months post‐COVID hospital discharge compared to levels in sera from healthy controls. Results are illustrated on a log scale, and the mean ± standard error is indicated for each group. Depending on the data distribution, unpaired t‐tests or Mann‐Whitney tests were used to determine statistical significance. *p < .05; **p < .01; ***p < .001; and ****p < .0001
FIGURE 2
FIGURE 2
TH2 and TH17 cytokines in post‐COVID patients. Sera from patients 3–9 months post‐COVID hospital discharge are significantly different compared to healthy controls for TH2 cytokines (A) and TH17 cytokines (B). Results are illustrated on a log scale, and the mean ± standard error is indicated for each group. Depending on the data distribution, unpaired t‐tests or Mann‐Whitney tests were used to determine statistical significance. *p < .05; **p < .01; and ***p < .001

References

    1. Amenta EM, Spallone A, Rodriguez‐Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID‐19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509. - PMC - PubMed
    1. Sokolowska M, Lukasik ZM, Agache I, et al. Immunology of COVID‐19: mechanisms, clinical outcome, diagnostics, and perspectives‐A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020;75(10):2445‐2476. - PMC - PubMed
    1. Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19. Allergy. 2020;75(7):1564‐1581. - PMC - PubMed
    1. Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL‐1 to IL‐38), interferons, transforming growth factor β, and TNF‐α: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984‐1010. - PubMed
    1. Bonaventura A, Vecchié A, Dagna L, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID‐19. Nat Rev Immunol. 2021;21(5):319‐329. - PMC - PubMed